Bharat Parenterals Ltd. reported financial results for Q1FY25 with increased revenues and profits, but a consolidated net loss due to operational expenses at lnnoxel Lifesciences.
AI Assistant
Bharat Parenterals Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.